As contagious viruses, such as the Coronavirus (2019-nCoV), continue to spread worldwide this winter, it’s more important now than ever to ensure the proper sanitation and cleaning is done to help prevent the spreading of these viruses.
According to a press release from Virox, makers of Rejuvenate disinfecting products, in cases of Emerging Pathogens such as 2019-nCoV, the EPA implements the Emerging Viral Pathogens Guidance for Antimicrobial Products. This guidance utilizes an organism hierarchy to identify effective products for use with emerging pathogens and to permit registrants to make limited statements against such pathogens. Coronaviruses are enveloped viruses, which are among the easiest organisms for disinfectants to kill or inactivate. The following criteria is used to determine efficacy of a disinfectant upon activation of the Emerging Pathogen rule: The product must be a hospital or broad-spectrum disinfectant product registered with EPA; and for an emerging enveloped virus, the product must have acceptable efficacy data previously submitted to and reviewed by the Agency against one non-enveloped virus (Poliovirus).
The press release also indicates that the Rejuvenate line of disinfectants (concentrate, ready-to-use, and premoistened wipes) have demonstrated effectiveness against viruses similar to 2019-nCoV on hard, nonporous surfaces, so Virox is recommending Rejuvenate products when used in accordance with the directions for use against Poliovirus type 1 on hard, non-porous surfaces, to help prevent against 2019-nCoV and other viruses. Refer to the CDC website for additional information.